Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia

Ana María Ríos, Mónica Fonseca-Aten, Asunción Mejías, Susana Chávez-Bueno, Kathy Katz, Ana María Gómez, George H. McCracken, Octavio Ramilo, R. Doug Hardy

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We evaluated the efficacy of azithromycin therapy given as a single high dose or divided over 5 days for the treatment of mild experimental Mycoplasma pneumoniae pneumonia. Although both azithromycin regimens significantly reduced quantitative cultures, lung histopathology, and pulmonary cytokines and chemokines, there were no significant differences between the two regimens.

Original languageEnglish (US)
Pages (from-to)3970-3973
Number of pages4
JournalAntimicrobial Agents and Chemotherapy
Volume49
Issue number9
DOIs
StatePublished - Sep 2005

Fingerprint

Mycoplasma Pneumonia
Mycoplasma pneumoniae
Azithromycin
Lung
Chemokines
Cytokines
Therapeutics

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. / Ríos, Ana María; Fonseca-Aten, Mónica; Mejías, Asunción; Chávez-Bueno, Susana; Katz, Kathy; Gómez, Ana María; McCracken, George H.; Ramilo, Octavio; Hardy, R. Doug.

In: Antimicrobial Agents and Chemotherapy, Vol. 49, No. 9, 09.2005, p. 3970-3973.

Research output: Contribution to journalArticle

Ríos, Ana María ; Fonseca-Aten, Mónica ; Mejías, Asunción ; Chávez-Bueno, Susana ; Katz, Kathy ; Gómez, Ana María ; McCracken, George H. ; Ramilo, Octavio ; Hardy, R. Doug. / Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. In: Antimicrobial Agents and Chemotherapy. 2005 ; Vol. 49, No. 9. pp. 3970-3973.
@article{e764a5156e5343028cb1ff20783bc6c1,
title = "Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia",
abstract = "We evaluated the efficacy of azithromycin therapy given as a single high dose or divided over 5 days for the treatment of mild experimental Mycoplasma pneumoniae pneumonia. Although both azithromycin regimens significantly reduced quantitative cultures, lung histopathology, and pulmonary cytokines and chemokines, there were no significant differences between the two regimens.",
author = "R{\'i}os, {Ana Mar{\'i}a} and M{\'o}nica Fonseca-Aten and Asunci{\'o}n Mej{\'i}as and Susana Ch{\'a}vez-Bueno and Kathy Katz and G{\'o}mez, {Ana Mar{\'i}a} and McCracken, {George H.} and Octavio Ramilo and Hardy, {R. Doug}",
year = "2005",
month = "9",
doi = "10.1128/AAC.49.9.3970-3973.2005",
language = "English (US)",
volume = "49",
pages = "3970--3973",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia

AU - Ríos, Ana María

AU - Fonseca-Aten, Mónica

AU - Mejías, Asunción

AU - Chávez-Bueno, Susana

AU - Katz, Kathy

AU - Gómez, Ana María

AU - McCracken, George H.

AU - Ramilo, Octavio

AU - Hardy, R. Doug

PY - 2005/9

Y1 - 2005/9

N2 - We evaluated the efficacy of azithromycin therapy given as a single high dose or divided over 5 days for the treatment of mild experimental Mycoplasma pneumoniae pneumonia. Although both azithromycin regimens significantly reduced quantitative cultures, lung histopathology, and pulmonary cytokines and chemokines, there were no significant differences between the two regimens.

AB - We evaluated the efficacy of azithromycin therapy given as a single high dose or divided over 5 days for the treatment of mild experimental Mycoplasma pneumoniae pneumonia. Although both azithromycin regimens significantly reduced quantitative cultures, lung histopathology, and pulmonary cytokines and chemokines, there were no significant differences between the two regimens.

UR - http://www.scopus.com/inward/record.url?scp=24144436945&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144436945&partnerID=8YFLogxK

U2 - 10.1128/AAC.49.9.3970-3973.2005

DO - 10.1128/AAC.49.9.3970-3973.2005

M3 - Article

VL - 49

SP - 3970

EP - 3973

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 9

ER -